Man

Francisco Xavier Zamora Vargas

MEDICO ESPECIALISTA

HOSPITAL BARROS LUCO

SANTIAGO, Chile

Líneas de Investigación


Estudios Clínicos en enfermedades infecciosas basados en infección VIH y enfermedades oportunistas Ensayos Clínicos en nuevas terapias para VHC Eficacia clínica y microbiologica en la dosificación de colistin en infecciones Bacterias multiresistente

Educación

  •  Medico, UNIVERSIDAD DE SANTIAGO DE CHILE. Chile, 2000

Experiencia Académica

  •   ACADEMICO Part Time

    UNIVERSIDAD DE SANTIAGO DE CHILE

    CIENCIAS MEDICAS

    Santiago de Chile, Chile

    2014 - A la fecha

Experiencia Profesional

  •   MEDICO ESPECIALISTA Part Time

    HOSPITAL BARROS LUCO TRUDEAU

    Santiago de Chile, Chile

    2014 - A la fecha

  •   MEDICO ESPECIALISTA Part Time

    HOSPITAL DE URGENCIA Y ASISTENCIA PUBLICA

    Santiago de Chile, Chile

    2014 - A la fecha

  •   MEDICO ESPECIALISTA Full Time

    HOSPITAL LA PAZ

    Madrid, España

    2009 - 2014

  •   MEDICO RESIDENTE Full Time

    HOSPITAL LA PAZ

    MADRID, Chile

    2004 - 2009


 

Article (11)

Switching from tenofovir containing regimens to boosted protease inhibitor monotherapy: Impact on renal function
Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study
A Prospective Cohort Study of Neurocognitive Function in Aviremic HIV-Infected Patients Treated With 1 or 3 Antiretrovirals
Effects of Sustained Viral Response in Patients With HIV and Chronic Hepatitis C and Nonadvanced Liver Fibrosis
Efficacy of a dual therapy based on darunavir/ritonavir and etravirine in ART-experienced patients
Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study
Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients
Anal Carcinoma in an HIV-Infected Woman
Hypertension, HIV infection, and highly active antiretroviric therapy
11
Francisco Zamora

MEDICO ESPECIALISTA

MEDICINA INTERNA

HOSPITAL BARROS LUCO

SANTIAGO, Chile